Brief: Bioporto Sees FY 2023 Revenue Between Approximately DKK 30 Mln To 33 Mln
March 29 (Reuters) - Bioporto A/S BIOPOR.CO :
* BIOPORTO ANNOUNCES FINANCIAL GUIDANCE FOR 2023
* SEES FY23 REVENUE BETWEEN APPROXIMATELY DKK 30 MILLION TO
33
MILLION
* WHILE FDA APPROVAL IS PENDING, COSTS RELATED TO FUTURE
CLINICAL
STUDIES ARE ASSUMED TO BE LOWER THAN IN 2022
* SEES 2023 ADJUSTED EBITDA LOSS OF APPROXIMATELY DKK 60
MILLION
TO DKK 65 MILLION
Source text for Eikon: ID:nGNE2hqmSf
Further company coverage: BIOPOR.CO
((Reuters.Briefs@thomsonreuters.com;))